Market closedNon-fractional

Corcept Therapeutics/CORT

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Corcept Therapeutics

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Ticker

CORT

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Menlo Park, United States

Employees

352

CORT Metrics

BasicAdvanced
$3.3B
Market cap
29.93
P/E ratio
$1.05
EPS
0.48
Beta
-
Dividend rate
$3.3B
0.48
5.179
4.879
0.014
11.97%
21.91%
29.93
6.17
6
6
25.89
26.51%
30.12%
15.47%
10.56%

What the Analysts think about CORT

Analyst Ratings

Majority rating from 5 analysts.
Buy

CORT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
18.86% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$147M
8.42%
Net income
$28M
-11.50%
Profit margin
18.86%
-18.39%

CORT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 13.64%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.25
$0.28
$0.28
$0.25
-
Expected
$0.15
$0.22
$0.26
$0.22
$0.23
Surprise
66.67%
28.24%
8.53%
13.64%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Corcept Therapeutics stock?

Corcept Therapeutics (CORT) has a market cap of $3.3B as of July 04, 2024.

What is the P/E ratio for Corcept Therapeutics stock?

The price to earnings (P/E) ratio for Corcept Therapeutics (CORT) stock is 29.93 as of July 04, 2024.

Does Corcept Therapeutics stock pay dividends?

No, Corcept Therapeutics (CORT) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Corcept Therapeutics dividend payment date?

Corcept Therapeutics (CORT) stock does not pay dividends to its shareholders.

What is the beta indicator for Corcept Therapeutics?

Corcept Therapeutics (CORT) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Corcept Therapeutics stock

Buy or sell Corcept Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing